Previous 10 | Next 10 |
Anchiano Therapeutics (ANCN) +66%.Second Sight Medical Products (EYES) +38%.OpGen (OPGN) +29% after publication of final study results of Unyvero HPN Panel.Net Element (NETE) +19% on strategic partnership with Mullen technologies.Athene Holding Ltd. (ATH) +18%...
MORRISVILLE, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will present at the virtual H.C. Wainwright Global Life Science...
Will March be the Month That These Biotech Penny Stocks Jump? Over the past year, the attention paid to biotech penny stocks has continued to increase. While it’s easy to assume that this is only due to the coronavirus, there are some other factors at play. Now we can’...
Gainers: NanoViricides, Inc. (NNVC) +89%.Communications Systems, Inc. (JCS) +74%.Amyris, Inc. (AMRS) +41%.Hovnanian Enterprises, Inc. (HOV) +37%.Rocket Companies, Inc. (RKT) +36%.Perion Network Ltd. (PERI) +27%.The OLB Group, Inc. (OLB) +25%.Novan, Inc. (NOVN) +21%.Aemetis, Inc. (AMTX) +21%.S...
MORRISVILLE, N.C., March 02, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the election of Steven D. Skolsky to its Board of Directors. Mr. Skolsky is a well-established senior executive with over 35 years o...
Penny Stocks to Watch as the Market Rebounds There was definitely a concern among investors recently. However, March may present a new, bullish case for penny stocks . As Monday, March 1st hit, most of the stock market was up by large numbers. By midday, the S&P 500 was up by ar...
ASLAN Pharmaceuticals Limited (ASLN) +71% as ASLAN004 shows positive effect in atopic dermatitis.Apollo Endosurgery (APEN) +47% after receiving a Breakthrough Device Designation from the USFDA for the Orbera® Intragastric Balloon.electroCore (ECOR) +39% on exclusive distri...
Novan (NOVN): FY GAAP EPS of -$0.30 beats by $0.02.Revenue of $4.92M (+0.4% Y/Y) misses by $0.17M.Press Release For further details see: Novan EPS beats by $0.02, misses on revenue
– B-SIMPLE4 pivotal Phase 3 trial evaluating SB206 as a treatment for molluscum contagiosum progressing with top-line efficacy results targeted before the end of Q2 2021 – – Company targeting initiating preclinical studies for intranasal formulation of b...
Are These Penny Stocks On Your Watch List Right Now? What are penny stocks ? According to the U.S. Securities and Exchange Commission, these are shares of companies trading for less than $5. While many traders carry their own definition of penny stocks, this is the standard issue an...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...